|
Description of event according to study: endoleak of unknown type 5 years post-implant on (b)(6) 2012, the patient received one ztlp-pt-38-167-ci proximal component.There was no difficulty deploying the device.Coil embolization of the left subclavian artery was performed after device deployment.On the completion angiogram, the core lab noted that the devices were patent with no kink or endoleak.The patient was discharged from the hospital on (b)(6) 2012 (three days post-procedure).Follow-up ct scans on (b)(6) 2012 (1-month follow-up, 23 days post-procedure) analysis: ulcer depth 24 mm.Devices patent and intact with no kinks or endoleaks.On (b)(6) 2012 (6-month follow-up, 186 days post-procedure) analysis: ulcer depth 24 mm.Devices patent and intact with no migration, kinks or endoleaks.On (b)(6) 2013 (12-month follow-up, 368 days post-procedure) analysis: ulcer depth 25 mm.Devices patent and intact with no migration, kinks or endoleaks.On (b)(6) 2014 (2-year follow-up, 732 days post-procedure) analysis: ulcer depth 22 mm.Devices patent and intact with no migration, kinks or endoleaks.On (b)(6) 2015 (3-year follow-up, 1082 days post-procedure) analysis: ulcer depth 20 mm.Devices patent and intact with no migration, kinks or endoleaks.On (b)(6) 2016 (4-year follow-up, 1460 days post-procedure) analysis: ulcer depth 21 mm.Devices patent and intact with no migration, kinks or endoleaks.1on (b)(6) 2017 (5-year follow-up, 1817 days post-procedure) analysis: ulcer depth 21 mm.Devices patent and intact with no migration or kinks.An endoleak of unknown type was noted.Patient outcome: the patient has completed the 5-year follow-up and has exited the study.No adverse events related to the device have been reported and secondary interventions have been performed.
|
|
Exemption number e2016032.William cook europe aps (manufacturer) is submitting this report on behalf of cook medical incorporated (cmi) (importer).Manufacturer ref# (b)(4).G1) name and address for importer site: cook medical incorporated (cmi) 400 daniels way bloomington, in 47404 registration no.: 3005580113.Summary of investigational findings: a very small arterial phase endoleak representing either a type 2 endoleak or a type 3 suture hole endoleak was confirmed.The leak was variably visible throughout the follow ups and appeared adjacent to the endograft surface, at the trailing edge of a second mainbody stent, where the endograft folded as it conformed to aortic tortuosity.Lts location near the endograft surface and the appearance at 36 months suggesting a pinhole endoleak originating at a stent strut supports a type 3 suture hole endoleak.The folded endograft fabric had a greater potential to enlarge the suture holes over time.The stable aneurysm volume indicates that the leak is still very small or a type 2 endoleak.No evidence to suggest that the device was not manufactured according to specification.Cook medical will continue to monitor for similar events.
|